Literature DB >> 29926082

Association of Multifocal Fibromuscular Dysplasia in Elderly Patients With a More Benign Clinical Phenotype: Data From the US Registry for Fibromuscular Dysplasia.

Imad Bagh1, Jeffrey W Olin2, James B Froehlich3, Eva Kline-Rogers3, Bruce Gray4, Esther S H Kim5, Aditya Sharma6, Ido Weinberg7, Bryan J Wells8, Xiaokui Gu3, Heather L Gornik1.   

Abstract

Importance: Fibromuscular dysplasia (FMD) is a nonatherosclerotic arterial disease that predominately affects women and is most commonly diagnosed in middle age. The natural history of FMD among patients diagnosed at an older age is not well understood. Objective: To examine the differences in clinical presentation, arterial bed involvement, vascular events, and need for vascular procedures between younger and older patients with FMD. Design, Setting, and Participants: Analysis of baseline data for patients enrolled in the US Registry for FMD as of December 15, 2016, at referral centers participating in the US Registry for FMD. Patients 18 years and older at the time of enrollment and those with only confirmed multifocal (string of beads type) FMD were included. Patients were categorized according to age at the time of diagnosis (≥65 years vs <65 years). Main Outcomes and Measures: Prevalence of specific symptoms, vascular events, and prior vascular procedures at the time of enrollment in the registry.
Results: A total of 1016 patients were included in the analysis, of whom, 170 (16.7%) were 65 years or older at the time of diagnosis. Older patients with FMD were more likely to be asymptomatic at the time of diagnosis (4.2% vs 1.4%; P = .02). Headache and pulsatile tinnitus, both common manifestations of FMD, were less common in older patients (40.5% vs 69.1%; P < .001 and 30% vs 44.6%; P < .001, respectively). Extracranial carotid arteries were more commonly involved in patients 65 years or older at time of diagnosis (87% vs 79.4%; P = .03). There was no difference in prevalence of renal artery involvement, number of arterial beds involved, or diagnosis of any aneurysm. Patients 65 years or older were less likely to have had a major vascular event (37.1% vs 46.1%; P = .03) and fewer had undergone a therapeutic vascular procedure (18.5% vs 33.1%; P < .001). Conclusions and Relevance: In the US Registry for FMD, patients 65 years or older at the time of diagnosis of multifocal FMD were more likely to be asymptomatic, had lower prevalence of major vascular events, and had undergone fewer therapeutic vascular procedures than younger patients. Patients with multifocal FMD diagnosed at an older age may have a more benign phenotype and fewer symptoms.

Entities:  

Mesh:

Year:  2018        PMID: 29926082      PMCID: PMC6143076          DOI: 10.1001/jamacardio.2018.1638

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


  14 in total

1.  Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association.

Authors:  Jeffrey W Olin; Heather L Gornik; J Michael Bacharach; Jose Biller; Lawrence J Fine; Bruce H Gray; William A Gray; Rishi Gupta; Naomi M Hamburg; Barry T Katzen; Robert A Lookstein; Alan B Lumsden; Jane W Newburger; Tatjana Rundek; C John Sperati; James C Stanley
Journal:  Circulation       Date:  2014-02-18       Impact factor: 29.690

Review 2.  Epidemiology of uncontrolled hypertension in the United States.

Authors:  Thomas J Wang; Ramachandran S Vasan
Journal:  Circulation       Date:  2005-09-13       Impact factor: 29.690

3.  High Prevalence of Multiple Arterial Bed Lesions in Patients With Fibromuscular Dysplasia: The ARCADIA Registry (Assessment of Renal and Cervical Artery Dysplasia).

Authors:  Pierre-François Plouin; Jean-Philippe Baguet; Frédéric Thony; Olivier Ormezzano; Arshid Azarine; François Silhol; Catherine Oppenheim; Béatrice Bouhanick; Louis Boyer; Alexandre Persu; Frank Hammer; Philippe Gosse; Claire Mounier-Vehier; Claire Le Hello; Xavier Jeunemaitre; Michel Azizi; Laurence Amar; Gilles Chatellier; Elie Mousseaux; Emmanuel Touzé
Journal:  Hypertension       Date:  2017-07-17       Impact factor: 10.190

4.  Prevalence of extracoronary vascular abnormalities and fibromuscular dysplasia in patients with spontaneous coronary artery dissection.

Authors:  Megha Prasad; Marysia S Tweet; Sharonne N Hayes; Shuai Leng; Jackson J Liang; Mackram F Eleid; Rajiv Gulati; Terri J Vrtiska
Journal:  Am J Cardiol       Date:  2015-03-23       Impact factor: 2.778

5.  The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients.

Authors:  Jeffrey W Olin; James Froehlich; Xiaokui Gu; J Michael Bacharach; Kim Eagle; Bruce H Gray; Michael R Jaff; Esther S H Kim; Pam Mace; Alan H Matsumoto; Robert D McBane; Eva Kline-Rogers; Christopher J White; Heather L Gornik
Journal:  Circulation       Date:  2012-05-21       Impact factor: 29.690

6.  Spontaneous coronary artery dissection: association with predisposing arteriopathies and precipitating stressors and cardiovascular outcomes.

Authors:  Jacqueline Saw; Eve Aymong; Tara Sedlak; Christopher E Buller; Andrew Starovoytov; Donald Ricci; Simon Robinson; Tycho Vuurmans; Min Gao; Karin Humphries; G B John Mancini
Journal:  Circ Cardiovasc Interv       Date:  2014-10-07       Impact factor: 6.546

7.  Renovascular hypertension secondary to arterial fibrodysplasia in adults: criteria for operation and results of surgical therapy.

Authors:  J C Stanley; W J Fry
Journal:  Arch Surg       Date:  1975-08

8.  Dissection and Aneurysm in Patients With Fibromuscular Dysplasia: Findings From the U.S. Registry for FMD.

Authors:  Daniella Kadian-Dodov; Heather L Gornik; Xiaokui Gu; James Froehlich; J Michael Bacharach; Yung-Wei Chi; Bruce H Gray; Michael R Jaff; Esther S H Kim; Pamela Mace; Aditya Sharma; Eva Kline-Rogers; Christopher White; Jeffrey W Olin
Journal:  J Am Coll Cardiol       Date:  2016-07-12       Impact factor: 24.094

9.  Association between 2 angiographic subtypes of renal artery fibromuscular dysplasia and clinical characteristics.

Authors:  Sébastien Savard; Olivier Steichen; Arshid Azarine; Michel Azizi; Xavier Jeunemaitre; Pierre-François Plouin
Journal:  Circulation       Date:  2012-11-15       Impact factor: 29.690

Review 10.  Recent developments in the understanding and management of fibromuscular dysplasia.

Authors:  Sarah C O'Connor; Heather L Gornik
Journal:  J Am Heart Assoc       Date:  2014-12       Impact factor: 5.501

View more
  3 in total

Review 1.  Renovascular Hypertension.

Authors:  Sandra M Herrmann; Stephen C Textor
Journal:  Endocrinol Metab Clin North Am       Date:  2019-09-19       Impact factor: 4.741

Review 2.  Current progress in clinical, molecular, and genetic aspects of adult fibromuscular dysplasia.

Authors:  Alexandre Persu; Piotr Dobrowolski; Heather L Gornik; Jeffrey W Olin; David Adlam; Michel Azizi; Pierre Boutouyrie; Rosa Maria Bruno; Marion Boulanger; Jean-Baptiste Demoulin; Santhi K Ganesh; Tomasz J Guzik; Magdalena Januszewicz; Jason C Kovacic; Mariusz Kruk; Peter de Leeuw; Bart L Loeys; Marco Pappaccogli; Melanie H A M Perik; Emmanuel Touzé; Patricia Van der Niepen; Daan J L Van Twist; Ewa Warchoł-Celińska; Aleksander Prejbisz; Andrzej Januszewicz
Journal:  Cardiovasc Res       Date:  2022-01-07       Impact factor: 10.787

Review 3.  Fibromuscular dysplasia with recurrence after "long-term" following percutaneous transcatheter renal angioplasty: two case reports with a review of 26 patients.

Authors:  Shuntaro Oribe; Takafumi Toyohara; Eikan Mishima; Takehiro Suzuki; Koichi Kikuchi; Shun Watanabe; Yoshiaki Morita; Hideki Ota; Kazumasa Seiji; Mariko Miyazaki; Kei Takase; Takaaki Abe
Journal:  BMC Nephrol       Date:  2021-05-20       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.